Integrative Oncology Outcomes Study in Breast Cancer

Status:	Completed
Conditions:	Breast Cancer, Cancer
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	4/17/2018
Start Date:	August 2010
End Date:	December 31, 2017

Breast Cancer Integrative Oncology: Prospective Matched Controlled Outcomes Study

This NIH-NCCAM funded epidemiologic research is being conducted as an observational
prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and
Integrated Oncology (IO) and their effects on breast cancer patients in community settings.

Hypothesis: IO services improve patients' quality of life and decrease cancer recurrence
rates in breast cancer patients as compared to women with similar disease states and
prognoses who do not receive IO care, and may or may not use CAM treatment on their own.

The patients enrolled into the study will include patients who meet the following criteria:

Cohort 1: IO clinic breast cancer patients

1. Confirmed breast cancer of primary breast cancer with ICD9 code of 174.x, 233.0 or
V10.3

2. Female

3. ≥18 years of age

4. Can provide signed informed consent

5. 1st IO clinic visit ≤3 months prior to enrollment

6. Can read and understand the questionnaires

Cohort 1A: Sub-cohort of IO clinic patients (cases) who meet the following additional
criteria and for whom matched controls have been found from the CSS database.

1. ICD9 code of 174.x or 233.0

2. Primary ductal or lobular breast cancer diagnosis ≤2 years prior to 1st IO clinic
visit

3. Minimum of two IO clinic visits within 7 months

4. Provided Baseline Questionnaire

Cohort 2: Matched controls from CSS database for Cohort 1A patients

1. Confirmed breast cancer

2. Female

3. ≥ 18 years of age

4. Can provide informed consent

We found this trial at

sites

Red Cedar Wellness Center

Bellevue, Washington 98004

from

Bellevue, WA